Enveda Therapeutics
Enveda Biosciences is a Colorado-based biotechnology company that provides plant-powered drug discovery and development solutions for the pharmaceutical sector.
Work at Enveda Therapeutics in HR or recruiting? Claim this page
Annual revenue
~$10M
Total funding
$324M
Last round Series C, Feb 2025
H1B filings, FY2026
4
Sponsors visas
Funding rounds
Total funding$324M
Funding rounds5
Investors29
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Feb 2025 | Series C | $20M | 1 | |
| Nov 2024 | Series C | $130M | 10 | |
| Jun 2024 | Series B | $55M | 9 | |
| Apr 2023 | Series B | $51M | 5 | |
| Dec 2022 | Series B | $68M | 11 |
H-1B sponsorship
H-1B Sponsorship Limited
H-1B Filings by Department
Finance2
Operations2
Engineering1
Executive1
Historical LCA Filings
20264
20252
The department split adds up all the years listed above. FY2026 alone: 4 filings.
Peer reviews
Worked with someone at Enveda Therapeutics?
Anonymous peer reviews on OffTheRecord
Enveda Therapeutics FAQ
Does Enveda Therapeutics sponsor H1B visas?
Yes. Enveda Therapeutics filed 4 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Operations roles.
How much funding has Enveda Therapeutics raised?
Enveda Therapeutics has raised $324M in total funding; its latest round was Series C in Feb 2025.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.